Dr. Anzueto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7703 Floyd Curl Dr
# MC7977
San Antonio, TX 78229Phone+1 210-257-1400Fax+1 210-257-1428
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1987 - 1988
- Universidad de San Carlos FOMSClass of 1979
Certifications & Licensure
- TX State Medical License 1991 - 2025
- OK State Medical License 1989 - 1992
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Acute Respiratory Distress Syndrome Clinical Network (ARDSNet) Start of enrollment: 1994 Sep 01
- Fluids and Catheters Treatment Trial (FACTT) - ARDS Clinical Research Network
- Long-term Oxygen Treatment Trial Start of enrollment: 2009 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1563 citationsGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.Michael S. Niederman, Lionel A. Mandell, Antonio Anzueto, J. B. Bass, W. A. Broughton
American Journal of Respiratory and Critical Care Medicine. 2001-06-01 - 4229 citationsInfectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsLionel A. Mandell, Richard G. Wunderink, Antonio Anzueto, John G. Bartlett, G. Douglas Campbell
Clinical Infectious Diseases. 2007-03-01 - 64 citationsLow-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.G Umberto Meduri, Mei-Chiung Shih, Lisa Bridges, Thomas J Martin, Ali El-Solh
Intensive Care Medicine. 2022-08-01
Press Mentions
- Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD PatientsMay 24th, 2023
- Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023May 2nd, 2023
- Boehringer Ingelheim Welcomes New 2023 GOLD Report Positioning LAMA/LABA as the Preferred Treatment for the Majority of Patients with COPDNovember 17th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: